ArticlePharmaceutical research1999

Improved lipid lowering activity of bezafibrate following continuous gastrointestinal administration: pharmacodynamic rationale for sustained release preparation of the drug.

A Hoffman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.